Human lymphocyte antigens in Graves' disease

Correlation with persistent course of disease

M. Baldini, M. Pappalettera, L. Lecchi, A. Orsatti, L. Meroni, R. Tozzi, M. Scalamogna, L. Cantalamessa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Graves' disease is a thyroid autoimmune disorder associated with specific human lymphocyte antigen (HLA) alleles, characterized by an unpredictable long-term course. To investigate possible relations between HLA phenotype and outcome of the disease, the authors typed for HLA antigens in 105 patients with Graves' disease with different course of disease. All patients were treated with antithyroid drugs for at least 12 months; 29 patients had stable remission 24 or more months after withdrawal of treatment; 76 patients had persistent disease-66 unremitting/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more months after onset of disease. The following findings emerged from this study: 1) HLA B8 and DR3 were increased significantly in Graves' patients versus 6,682 control subjects from the same geographic area (23.80% vs 12.01%, odds ratio [OR] 1.98, and 31.43% vs 18.00%, OR 1.75, respectively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3 were significantly more frequent in Graves' patients vs control subjects; in addition, these combinations were present exclusively in patients with persistent disease (B8-DR3 28.95%, OR 7.14, B8-Cw7-DR3 27.63%, OR 11.24, and A1-B8-Cw7-DR3 18.42%, OR 11.29). These data provide evidence that not only susceptibility to Graves' disease, but also persistent activity of the autoimmune process, producing either hyperthyroidism or stable hypothyroidism, is associated with specific HLA antigen phenotypes.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalAmerican Journal of the Medical Sciences
Volume309
Issue number1
Publication statusPublished - 1995

Fingerprint

Graves Disease
Lymphocytes
Antigens
Odds Ratio
Hyperthyroidism
Hypothyroidism
Phenotype
Antithyroid Agents
Thyroid Gland
Alleles

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Baldini, M., Pappalettera, M., Lecchi, L., Orsatti, A., Meroni, L., Tozzi, R., ... Cantalamessa, L. (1995). Human lymphocyte antigens in Graves' disease: Correlation with persistent course of disease. American Journal of the Medical Sciences, 309(1), 43-48.

Human lymphocyte antigens in Graves' disease : Correlation with persistent course of disease. / Baldini, M.; Pappalettera, M.; Lecchi, L.; Orsatti, A.; Meroni, L.; Tozzi, R.; Scalamogna, M.; Cantalamessa, L.

In: American Journal of the Medical Sciences, Vol. 309, No. 1, 1995, p. 43-48.

Research output: Contribution to journalArticle

Baldini, M, Pappalettera, M, Lecchi, L, Orsatti, A, Meroni, L, Tozzi, R, Scalamogna, M & Cantalamessa, L 1995, 'Human lymphocyte antigens in Graves' disease: Correlation with persistent course of disease', American Journal of the Medical Sciences, vol. 309, no. 1, pp. 43-48.
Baldini, M. ; Pappalettera, M. ; Lecchi, L. ; Orsatti, A. ; Meroni, L. ; Tozzi, R. ; Scalamogna, M. ; Cantalamessa, L. / Human lymphocyte antigens in Graves' disease : Correlation with persistent course of disease. In: American Journal of the Medical Sciences. 1995 ; Vol. 309, No. 1. pp. 43-48.
@article{425d27555b2f4b45beab152c707c7626,
title = "Human lymphocyte antigens in Graves' disease: Correlation with persistent course of disease",
abstract = "Graves' disease is a thyroid autoimmune disorder associated with specific human lymphocyte antigen (HLA) alleles, characterized by an unpredictable long-term course. To investigate possible relations between HLA phenotype and outcome of the disease, the authors typed for HLA antigens in 105 patients with Graves' disease with different course of disease. All patients were treated with antithyroid drugs for at least 12 months; 29 patients had stable remission 24 or more months after withdrawal of treatment; 76 patients had persistent disease-66 unremitting/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more months after onset of disease. The following findings emerged from this study: 1) HLA B8 and DR3 were increased significantly in Graves' patients versus 6,682 control subjects from the same geographic area (23.80{\%} vs 12.01{\%}, odds ratio [OR] 1.98, and 31.43{\%} vs 18.00{\%}, OR 1.75, respectively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3 were significantly more frequent in Graves' patients vs control subjects; in addition, these combinations were present exclusively in patients with persistent disease (B8-DR3 28.95{\%}, OR 7.14, B8-Cw7-DR3 27.63{\%}, OR 11.24, and A1-B8-Cw7-DR3 18.42{\%}, OR 11.29). These data provide evidence that not only susceptibility to Graves' disease, but also persistent activity of the autoimmune process, producing either hyperthyroidism or stable hypothyroidism, is associated with specific HLA antigen phenotypes.",
author = "M. Baldini and M. Pappalettera and L. Lecchi and A. Orsatti and L. Meroni and R. Tozzi and M. Scalamogna and L. Cantalamessa",
year = "1995",
language = "English",
volume = "309",
pages = "43--48",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Human lymphocyte antigens in Graves' disease

T2 - Correlation with persistent course of disease

AU - Baldini, M.

AU - Pappalettera, M.

AU - Lecchi, L.

AU - Orsatti, A.

AU - Meroni, L.

AU - Tozzi, R.

AU - Scalamogna, M.

AU - Cantalamessa, L.

PY - 1995

Y1 - 1995

N2 - Graves' disease is a thyroid autoimmune disorder associated with specific human lymphocyte antigen (HLA) alleles, characterized by an unpredictable long-term course. To investigate possible relations between HLA phenotype and outcome of the disease, the authors typed for HLA antigens in 105 patients with Graves' disease with different course of disease. All patients were treated with antithyroid drugs for at least 12 months; 29 patients had stable remission 24 or more months after withdrawal of treatment; 76 patients had persistent disease-66 unremitting/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more months after onset of disease. The following findings emerged from this study: 1) HLA B8 and DR3 were increased significantly in Graves' patients versus 6,682 control subjects from the same geographic area (23.80% vs 12.01%, odds ratio [OR] 1.98, and 31.43% vs 18.00%, OR 1.75, respectively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3 were significantly more frequent in Graves' patients vs control subjects; in addition, these combinations were present exclusively in patients with persistent disease (B8-DR3 28.95%, OR 7.14, B8-Cw7-DR3 27.63%, OR 11.24, and A1-B8-Cw7-DR3 18.42%, OR 11.29). These data provide evidence that not only susceptibility to Graves' disease, but also persistent activity of the autoimmune process, producing either hyperthyroidism or stable hypothyroidism, is associated with specific HLA antigen phenotypes.

AB - Graves' disease is a thyroid autoimmune disorder associated with specific human lymphocyte antigen (HLA) alleles, characterized by an unpredictable long-term course. To investigate possible relations between HLA phenotype and outcome of the disease, the authors typed for HLA antigens in 105 patients with Graves' disease with different course of disease. All patients were treated with antithyroid drugs for at least 12 months; 29 patients had stable remission 24 or more months after withdrawal of treatment; 76 patients had persistent disease-66 unremitting/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more months after onset of disease. The following findings emerged from this study: 1) HLA B8 and DR3 were increased significantly in Graves' patients versus 6,682 control subjects from the same geographic area (23.80% vs 12.01%, odds ratio [OR] 1.98, and 31.43% vs 18.00%, OR 1.75, respectively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3 were significantly more frequent in Graves' patients vs control subjects; in addition, these combinations were present exclusively in patients with persistent disease (B8-DR3 28.95%, OR 7.14, B8-Cw7-DR3 27.63%, OR 11.24, and A1-B8-Cw7-DR3 18.42%, OR 11.29). These data provide evidence that not only susceptibility to Graves' disease, but also persistent activity of the autoimmune process, producing either hyperthyroidism or stable hypothyroidism, is associated with specific HLA antigen phenotypes.

UR - http://www.scopus.com/inward/record.url?scp=0028872125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028872125&partnerID=8YFLogxK

M3 - Article

VL - 309

SP - 43

EP - 48

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 1

ER -